AURO-CEFTAZIDIME ceftazidime (as pentahydrate) 2g powder for injection vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Compre agora

Ingredientes ativos:

ceftazidime pentahydrate, Quantity: 2349 mg (Equivalent: ceftazidime, Qty 2000 mg)

Disponível em:

Strides Pharma Science Pty Ltd

DCI (Denominação Comum Internacional):

ceftazidime pentahydrate

Forma farmacêutica:

Injection, powder for

Composição:

Excipient Ingredients: sodium carbonate

Via de administração:

Intravenous

Unidades em pacote:

5 vials, 1 vial

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

AURO-CEFTAZIDIME is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. . Indications include the following.. Severe infections in general. For example: septicaemia (including neonatal sepsis), bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns.. Respiratory tract. For example: pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. Severe ear, nose and throat infections. For example: otitis media, mastoiditis.. Urinary tract. For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only); infections associated with bladder and renal stones.. Skin and soft tissue. . For example: erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.. Gastrointestinal and abdominal. . For example: intra-abdominal abscesses, enterocolitis.. Bone and joint. . For example: osteitis, osteomyelitis, septic arthritis, infected bursitis.

Resumo do produto:

Visual Identification: White or cream coloured powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Registered

Data de autorização:

2010-10-19